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Abstracts / International Journal of Surgery 23 (2015) S15eS134 S29TRAM ﬂaps. The risk factors for transfusion include obesity, peri-operative
anaemia and bilateral cases. There are contradictory reports regarding
immediate procedures being a risk factor. The data is variable with lack of
consistency, emphasising the importance of a systematic analysis of the
studies.
Conclusion: We have identiﬁed the most common predictors for
post operative transfusion for DIEP and TRAM ﬂaps. This information is
valuable to patients and clinicians during preoperative counselling and
consent.
0495: IMPROVING POST OPERATIVE PAIN MANAGEMENT IN SUB-
PECTORAL TISSUE EXPANDER IMPLANT RECONSTRUCTION OF THE
BREAST USING AN ELASTOMERIC PUMP
S. Hallam*, A. Chaudhry, A. Chambers, S. Govindarajulu, A. Sahu, S.
Cawthorn. North Bristol NHS Trust, UK
Aim: Postoperative pain after breast surgery leads to delayed mobilization
and prolonged stay. We performed a retrospective analysis of patients
undergoing skin-sparing mastectomy and subpectoral implant recon-
struction. Hypothesis: Does the use of an elastomeric local anaesthetic
pump improve pain control and length of stay (LOS).
Methods: 25 consecutive patients undergoing the above procedure were
sited with an elastomeric local anaesthetic infusion pump intra-opera-
tively, in addition to standard regular and PRN analgesia. The control group
contained 25 patients undergoing the same procedure receiving standard
analgesia alone. Visual Analogue Scales (VAS) were recorded at 24 hours in
addition to PRN analgesic requirements.
Results: Median age was 51 (26e75) in the intervention group and 50
(28e70) in the control. Mean VAS score was 0.28 (0.61SD) at 24 hours in
the intervention group and 1.84 (0.37SD) in the control, p<0.0001. Mean
LOS was 1.8 days (0.71 SD), and 2.28 days (0.94 SD) in the control, p¼0.252.
There were no complications involving catheter placement, local anaes-
thetic leakage or toxicity.
Conclusion: We found signiﬁcantly reduced pain and trend towards
reduced and length of stay with the local anaesthetic infusion pump. The
elastomeric pump is a step towards enhanced patient recovery following
mastectomy and implant reconstruction.
0521: EXPLORING THE POTENTIAL OF USING THE TRAINEE
COLLABORATIVE MODEL TO DELIVER HIGH-QUALITY, LARGE-SCALE
PROSPECTIVE MULTICENTRE STUDIES IN RECONSTRUCTIVE BREAST
SURGERY: THE IBRA (IMPLANT BREAST RECONSTRUCTION
EVALUATION) STUDY
On behalf of the Breast Reconstruction Research CollaborativeBreast
Reconstruction Research Collaborative, United Kingdom
Aim: The introduction of techniques to augment the subpectoral pocket
has revolutionalised the practice of implant-based breast recon-
struction(IBBR), but evidence to support the safety and efﬁcacy of these
techniques is lacking. High-quality data are required, but large pro-
spective cohort-studies are expensive and time-consuming. Adoption of
the trainee research collaborative model may effectively overcome
these barriers.
We report early experience with the iBRA(implant Breast Reconstruction
evAluation) study which has employed this innovative methodology in
breast-surgery for the ﬁrst time.
Methods: The iBRA study has 4-phases that aim to inform the feasibility
and conduct of a future RCT including a national practice ques-
tionnaire(NPQ) and prospective audit.
Trainee leads have been identiﬁed at each centre via the Mammary Fold
and Reconstructive Surgery Trials Network. Leads are responsible for
completing the NPQ with the support of a lead consultant and identifying
patients for the prospective audit, collecting in-hospital and 30-day
outcome data and obtaining consent for patient-reported outcome
questionnaires.
Results: Between May-Dec2014, 67 units have completed the NPQ. Over
100 collaborators have recruited 328 patients from 35 centres and the
study is running 6-months ahead of schedule.Conclusion: The iBRA study has demonstrated that the trainee collabo-
rative model is an effective means delivering large-scale prospective
studies in breast-surgery.
0529: LOCAL RECURRENCE FOLLOWING BREAST CONSERVING SURGERY
FOR DUCTAL CARCINOMA IN-SITU: THE EDINBURGH EXPERIENCE
G.E. Ekatah*, M.J. Dixon. Western General Hospital Edinburgh, UK
Aim: Ductal carcinoma in-situ (DCIS) represents 5% of symptomatic and
50% of screen-detected breast malignancies. Historically managed with
mastectomy, providing excellent long-term outcomes, Breast Conserving
Surgery (BCS) +/ adjuvant radiotherapy now represents the mainstay
management option for DCIS providing better cosmetic outcomes with no
adverse impact on overall survival. The main drawback of BCS remains
local recurrence e DCIS or invasive breast cancer, which are associated
with signiﬁcant morbidity and mortality. Given advances in DCIS man-
agement, the study aims to compare local recurrence rates as well as ‘time
to recurrence’ over the last 10 years to previously published data from the
Edinburgh breast unit.
Methods: Retrospective single-centre study of patients with histologically
conﬁrmed primary DCIS who underwent BCS between January 2000 and
January 2010.
Results: Of the 477 eligible patients, 7.8% (n¼37) developed local recur-
rence following BCS (median follow-up ¼ 63months), a signiﬁcant
decrease from 15% previously reported within the same unit. The median
time-to-recurrence was 27months. There is also trend towards decreasing
local recurrence rates with increasing use of adjuvant radiotherapy.
Conclusion: Advances in DCIS management and widespread use of adju-
vant radiotherapy have contributed to a signiﬁcant reduction in local
recurrence rates following BCS for DCIS.
0530: EXPLORING VARIATIONS IN THE PROVISION AND PRACTICE OF
IMPLANT-BASED BREAST RECONSTRUCTION IN THE UK: INITIAL
RESULTS FROM THE IBRA NATIONAL PRACTICE QUESTIONNAIRE
On behalf of the Breast Reconstruction Research CollaborativeBreast
Reconstruction Research Collaborative, United Kingdom
Aim: The introduction of lower-pole sling-procedures has revolutionised
the practice of implant-based breast-reconstruction (IBBR), but data
regarding the availability and practice of these procedures is limited. The
iBRA (implant Breast Reconstruction evAluation) Study aims to explore the
practice and outcomes of IBBR to inform the feasibility of undertaking an
RCT comparing techniques.
We report the early results of iBRA Phase-1, a National Practice Ques-
tionnaire (NPQ) which aims to comprehensively describe current national-
practice.
Methods: A questionnaire developed by the iBRA Steering-Group was
completed by trainee and consultant leads at breast and plastic surgical-
units across the UK. Simple summary statistics were calculated and vari-
ations in service-provision, practice and adherence to guidelines
evaluated.
Results: 44-units have completed the NPQ to-date. Variation was
demonstrated in the provision of novel-techniques especially the avail-
ability of biological (n¼32, 72.7%) and synthetic (n¼10, 20.5%)meshes and
in patient-selection. There was lack of consistency in peri and post-oper-
ative management particularly duration of antibiotic-use (induction-only-
vs.14-day-course) and drain-policy (no-drains-vs.2-drains-for-14-days).
Few units (n¼14, 37.8%) had written management protocols and only half
(n¼20) prospectively-audited their outcomes.
Conclusion: Early analysis of the iBRA-NPQ has demonstrated marked
variation in the provision and practice of IBBR. Phase-2 of the iBRA Study
will determine the safety and efﬁcacy of different approaches to IBBR and
allow evidence-based best practice to be explored.
0571: ARTISS HUMAN FIBRIN SEALANT GLUE FOR MASTECTOMY FLAP
ADHERENCE
M. Venn*, E. Babu. The Hillingdon Hospitals NHS Foundation Trust, UK
